MV

Mandar Vivekanand Kulkarni

Active Director Director DIN 08349630
DIN 08349630 First appointment Feb 2019 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Past companies –
Total affiliations 7 Since Feb 2019
Shareholding value •••• Premium profile

About Mandar Vivekanand Kulkarni

Data last updated:

Mandar Vivekanand Kulkarni has 7 years in corporate governance. Holds Director and Nominee Director roles. Currently with 7 companies, including Innohub Infra Private Limited and Innohub Infra Development Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹93.7 Lakh; the largest is Vyas Cancer Research Private Limited at ₹92.4 Lakh (FY 2022).

DIN 08349630
Primary Designation Director
First Appointment 02 Feb 2019
Oldest Company Age 11 yrs
Largest company Vyas Cancer Research Private Limited · ₹92.4 Lakh (FY 2022)
Combined revenue ₹93.7 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vyas Cancer Research Private Limited U85191AP2015PTC097487
Director02 Feb 20192015₹92.4 Lakh (FY 2022)Active
Translational Oncology Council U85300AP2020NPL115951
Director05 Oct 20202020₹1.3 Lakh (FY 2022)Active
Kkveda Healthcare Private Limited U86100DL2024PTC440116
Nominee Director20 Dec 20242024–Active
Skmahi Healthcare Private Limited U21002DL2024PTC427395
Nominee Director26 Feb 20242024–Active
Eliczen Lifesciences Private Limited U74999AP2016PTC103840
Director01 Aug 20232016–Active
Director10 Dec 20202020–Active
Innohub Infra Private Limited U70109AP2020PTC115636
Director17 Sep 20202020–Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Innohub Infra Private Limited
Innohub Infra Development Private Limited
Vyas Cancer Research Private Limited
Translational Oncology Council
Premium access

Shareholding and investment profile for Mandar Vivekanand Kulkarni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mandar Vivekanand Kulkarni

Mandar Vivekanand Kulkarni has 7 years in corporate governance. Holds Director and Nominee Director roles. Currently with 7 companies, including Innohub Infra Private Limited and Innohub Infra Development Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹93.7 Lakh; the largest is Vyas Cancer Research Private Limited at ₹92.4 Lakh (FY 2022).

Mandar Vivekanand Kulkarni is associated with 7 companies as Director and Nominee Director, including Vyas Cancer Research Private Limited (₹92.4 Lakh), Translational Oncology Council (₹1.3 Lakh), Kkveda Healthcare Private Limited.

Mandar Vivekanand Kulkarni has expertise in General Business, Healthcare.

Mandar Vivekanand Kulkarni has 7 years in corporate governance.

By reported revenue, the largest current company of Mandar Vivekanand Kulkarni is Vyas Cancer Research Private Limited, with revenue of ₹92.4 Lakh (FY 2022).

The 2 current companies of Mandar Vivekanand Kulkarni that report revenue have a combined latest revenue of ₹93.7 Lakh.

Mandar Vivekanand Kulkarni currently holds positions at 7 companies; the 5 largest by reported revenue are Vyas Cancer Research Private Limited (₹92.4 Lakh), Translational Oncology Council (₹1.3 Lakh), Kkveda Healthcare Private Limited, Skmahi Healthcare Private Limited, Eliczen Lifesciences Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available